"vismodegib" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-degib"
      },
      "expansion": "-degib",
      "name": "af"
    }
  ],
  "etymology_text": "Formed with -degib.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "vismodegib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -degib",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2016 March 3, “Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells”, in PLOS ONE, →DOI:",
          "text": "Among the inhibitors of the Hh pathway that interact directly with SMO, vismodegib and sonidegib are the two compounds approved by FDA in 2012 and 2015, respectively, for the treatment of basal cell carcinoma (BCC).",
          "type": "quote"
        }
      ],
      "glosses": [
        "A drug targeting the smoothened protein of the hedgehog signaling pathway, used for the treatment of basal cell carcinoma."
      ],
      "id": "en-vismodegib-en-noun-lSJf4PXw",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "smoothened",
          "smoothened#English:_protein"
        ],
        [
          "protein",
          "protein"
        ],
        [
          "treatment",
          "treatment"
        ],
        [
          "basal cell carcinoma",
          "basal cell carcinoma"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug targeting the smoothened protein of the hedgehog signaling pathway, used for the treatment of basal cell carcinoma."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "vismodegib"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-degib"
      },
      "expansion": "-degib",
      "name": "af"
    }
  ],
  "etymology_text": "Formed with -degib.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "vismodegib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms suffixed with -degib",
        "English terms with quotations",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2016 March 3, “Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells”, in PLOS ONE, →DOI:",
          "text": "Among the inhibitors of the Hh pathway that interact directly with SMO, vismodegib and sonidegib are the two compounds approved by FDA in 2012 and 2015, respectively, for the treatment of basal cell carcinoma (BCC).",
          "type": "quote"
        }
      ],
      "glosses": [
        "A drug targeting the smoothened protein of the hedgehog signaling pathway, used for the treatment of basal cell carcinoma."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "smoothened",
          "smoothened#English:_protein"
        ],
        [
          "protein",
          "protein"
        ],
        [
          "treatment",
          "treatment"
        ],
        [
          "basal cell carcinoma",
          "basal cell carcinoma"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug targeting the smoothened protein of the hedgehog signaling pathway, used for the treatment of basal cell carcinoma."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "vismodegib"
}